Bile Acid Signal Molecules Associate Temporally with Respiratory Inflammation and Microbiome Signatures in Clinically Stable Cystic Fibrosis Patients

Cystic fibrosis (CF) is a congenital disorder resulting in a multisystemic impairment in ion homeostasis. The subsequent alteration of electrochemical gradients severely compromises the function of the airway epithelia. These functional changes are accompanied by recurrent cycles of inflammation–infection that progressively lead to pulmonary insufficiency. Recent developments have pointed to the existence of a gut–lung axis connection, which may modulate the progression of lung disease. Molecular signals governing the interplay between these two organs are therefore candidate molecules requiring further clinical evaluation as potential biomarkers. We demonstrate a temporal association between bile acid (BA) metabolites and inflammatory markers in bronchoalveolar lavage fluid (BALF) from clinically stable children with CF. By modelling the BALF-associated microbial communities, we demonstrate that profiles enriched in operational taxonomic units assigned to supraglottic taxa and opportunistic pathogens are closely associated with inflammatory biomarkers. Applying regression analyses, we also confirmed a linear link between BA concentration and pathogen abundance in BALF. Analysis of the time series data suggests that the continuous detection of BAs in BALF is linked to differential ecological succession trajectories of the lung microbiota. Our data provide further evidence supporting a role for BAs in the early pathogenesis and progression of CF lung disease.

[1]  F. O'Gara,et al.  The Detection of Bile Acids in the Lungs of Paediatric Cystic Fibrosis Patients Is Associated with Altered Inflammatory Patterns , 2020, Diagnostics.

[2]  Peter T. McKenney,et al.  Bacterial metabolism of bile acids promotes peripheral Treg cell generation , 2020, Nature.

[3]  L. Hoffman,et al.  Lung function and microbiota diversity in cystic fibrosis , 2020, Microbiome.

[4]  A. Kassambara,et al.  Extract and Visualize the Results of Multivariate Data Analyses [R package factoextra version 1.0.7] , 2020 .

[5]  Jianguo Xia,et al.  Using MicrobiomeAnalyst for comprehensive statistical, functional, and meta-analysis of microbiome data , 2020, Nature Protocols.

[6]  C. Benoist,et al.  Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis , 2019, Nature.

[7]  D. Charnock-Jones,et al.  Human placenta has no microbiome but can harbour potential pathogens , 2019, Nature.

[8]  C. Goss,et al.  Direct Lung Sampling Indicates That Established Pathogens Dominate Early Infections in Children with Cystic Fibrosis. , 2019, Cell reports.

[9]  Arnaud Droit,et al.  A Generic Multivariate Framework for the Integration of Microbiome Longitudinal Studies With Other Data Types , 2019, bioRxiv.

[10]  Rob Knight,et al.  Contamination in Low Microbial Biomass Microbiome Studies: Issues and Recommendations. , 2019, Trends in microbiology.

[11]  P. Greally,et al.  Pulmonary aspiration in preschool children with cystic fibrosis , 2018, RESPIRATORY RESEARCH.

[12]  M. Fischbach,et al.  Bile acid metabolites control Th17 and Treg cell differentiation , 2018, bioRxiv.

[13]  D. Lüdecke Sjplot - Data Visualization For Statistics In Social Science. , 2018 .

[14]  Kassem M. Makki,et al.  The Impact of Dietary Fiber on Gut Microbiota in Host Health and Disease. , 2018, Cell host & microbe.

[15]  K. Nelson,et al.  Supragingival Plaque Microbiome Ecology and Functional Potential in the Context of Health and Disease , 2018, mBio.

[16]  M. Wolfgang,et al.  Initial acquisition and succession of the cystic fibrosis lung microbiome is associated with disease progression in infants and preschool children , 2018, PLoS pathogens.

[17]  Defa Li,et al.  Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice , 2017, BMC Biology.

[18]  D. Relman,et al.  Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data , 2017, Microbiome.

[19]  W. T. Harris,et al.  Airway microbiota across age and disease spectrum in cystic fibrosis , 2017, European Respiratory Journal.

[20]  F. O'Gara,et al.  Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism , 2017, Microbiome.

[21]  P. Sly,et al.  Early Lung Disease in Infants and Preschool Children with Cystic Fibrosis. What Have We Learned and What Should We Do about It? , 2017, American journal of respiratory and critical care medicine.

[22]  Kim-Anh Lê Cao,et al.  mixOmics: An R package for ‘omics feature selection and multiple data integration , 2017, bioRxiv.

[23]  Kristine M Wylie,et al.  The lower airway microbiota in early cystic fibrosis lung disease: a longitudinal analysis , 2017, Thorax.

[24]  A. Tierney,et al.  Effect of probiotics on respiratory, gastrointestinal and nutritional outcomes in patients with cystic fibrosis: A systematic review. , 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[25]  E. Sanders,et al.  Concordance between upper and lower airway microbiota in infants with cystic fibrosis , 2017, European Respiratory Journal.

[26]  Jeffrey L. Curtis,et al.  Bacterial Topography of the Healthy Human Lower Respiratory Tract , 2017, mBio.

[27]  B. Verdon,et al.  Effects of bile acids on human airway epithelial cells: implications for aerodigestive diseases , 2017, ERJ Open Research.

[28]  P. Hugenholtz,et al.  Emerging pathogenic links between microbiota and the gut–lung axis , 2016, Nature Reviews Microbiology.

[29]  Luca Scrucca,et al.  mclust 5: Clustering, Classification and Density Estimation Using Gaussian Finite Mixture Models , 2016, R J..

[30]  F. O'Gara,et al.  Dissecting the regulation of bile-induced biofilm formation in Staphylococcus aureus. , 2016, Microbiology.

[31]  F. O'Gara,et al.  Bile signalling promotes chronic respiratory infections and antibiotic tolerance , 2016, Scientific Reports.

[32]  L. Hoffman,et al.  The microbiota in bronchoalveolar lavage from young children with chronic lung disease includes taxa present in both the oropharynx and nasopharynx , 2016, Microbiome.

[33]  R. Hunter,et al.  Evidence and Role for Bacterial Mucin Degradation in Cystic Fibrosis Airway Disease , 2016, bioRxiv.

[34]  W. R. Wikoff,et al.  Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype , 2016, Nature Microbiology.

[35]  Kim-Anh Lê Cao,et al.  MixMC: A Multivariate Statistical Framework to Gain Insight into Microbial Communities , 2016, bioRxiv.

[36]  B. Marsland,et al.  The Gut-Lung Axis in Respiratory Disease. , 2015, Annals of the American Thoracic Society.

[37]  Marleen de Bruijne,et al.  PRAGMA-CF. A Quantitative Structural Lung Disease Computed Tomography Outcome in Young Children with Cystic Fibrosis. , 2015, American journal of respiratory and critical care medicine.

[38]  Peter Meinicke,et al.  Tax4Fun: predicting functional profiles from metagenomic 16S rRNA data , 2015, Bioinform..

[39]  M. Parkins,et al.  Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis. , 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[40]  Paul Turner,et al.  Reagent and laboratory contamination can critically impact sequence-based microbiome analyses , 2014, BMC Biology.

[41]  F. O'Gara,et al.  Bile Acids Repress Hypoxia-Inducible Factor 1 Signaling and Modulate the Airway Immune Response , 2014, Infection and Immunity.

[42]  J. Petrosino,et al.  The Placenta Harbors a Unique Microbiome , 2014, Science Translational Medicine.

[43]  F. O'Gara,et al.  Aspirated bile: a major host trigger modulating respiratory pathogen colonisation in cystic fibrosis patients , 2014, European Journal of Clinical Microbiology & Infectious Diseases.

[44]  M. Pop,et al.  Robust methods for differential abundance analysis in marker gene surveys , 2013, Nature Methods.

[45]  James B. Mitchell,et al.  Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity , 2013, Nature Communications.

[46]  Rohan S. Kulkarni,et al.  Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation , 2013, Microbiome.

[47]  Peter D Sly,et al.  Risk factors for bronchiectasis in children with cystic fibrosis. , 2013, The New England journal of medicine.

[48]  J. Lordan,et al.  Bile acids are present in the lower airways of people with cystic fibrosis. , 2012, American journal of respiratory and critical care medicine.

[49]  Pelin Yilmaz,et al.  The SILVA ribosomal RNA gene database project: improved data processing and web-based tools , 2012, Nucleic Acids Res..

[50]  F. O'Gara,et al.  Respiratory Pathogens Adopt a Chronic Lifestyle in Response to Bile , 2012, PloS one.

[51]  H. Sokol,et al.  Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases , 2012, Gut.

[52]  C. W. Davis,et al.  CFTR, mucins, and mucus obstruction in cystic fibrosis. , 2012, Cold Spring Harbor perspectives in medicine.

[53]  A. Klindworth,et al.  Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies , 2012, Nucleic acids research.

[54]  L. Dupont,et al.  Bile acids in sputum and increased airway inflammation in patients with cystic fibrosis. , 2012, Chest.

[55]  F. Bäckhed,et al.  Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. , 2013, Cell metabolism.

[56]  P. Sly,et al.  Progression of early structural lung disease in young children with cystic fibrosis assessed using CT , 2011, Thorax.

[57]  A. Bush,et al.  The Th17 pathway in cystic fibrosis lung disease. , 2011, American journal of respiratory and critical care medicine.

[58]  P. Sly,et al.  Infection, inflammation, and lung function decline in infants with cystic fibrosis. , 2011, American journal of respiratory and critical care medicine.

[59]  B. Dimitrov,et al.  High concentrations of pepsin in bronchoalveolar lavage fluid from children with cystic fibrosis are associated with high interleukin-8 concentrations , 2010, Thorax.

[60]  J. Lipuma The Changing Microbial Epidemiology in Cystic Fibrosis , 2010, Clinical Microbiology Reviews.

[61]  Hadley Wickham,et al.  ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .

[62]  J. Gustafson,et al.  Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.

[63]  P. Sly,et al.  Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. , 2009, American journal of respiratory and critical care medicine.

[64]  J. Elborn,et al.  Neutrophils in cystic fibrosis , 2008, Thorax.

[65]  G. Verleden,et al.  Gastro-oesophageal reflux and aspiration of gastric contents in adult patients with cystic fibrosis , 2008, Gut.

[66]  J. A. Aas,et al.  Defining the Normal Bacterial Flora of the Oral Cavity , 2005, Journal of Clinical Microbiology.

[67]  R. Henry,et al.  Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. , 2002, American journal of respiratory and critical care medicine.

[68]  Gerald B. Pier,et al.  Lung Infections Associated with Cystic Fibrosis , 2002, Clinical Microbiology Reviews.

[69]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA , 1989, Science.

[70]  V. Sutter Anaerobes as normal oral flora. , 1984, Reviews of infectious diseases.

[71]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[72]  Jelle J. Goeman,et al.  A global test for groups of genes: testing association with a clinical outcome , 2004, Bioinform..